Form 4: Orchestra BioMed Officer's Routine Tax Withholding
Insider Transaction Report
Orchestra BioMed's Principal Accounting Officer, Joshua Aiello, reported a disposition of 241 shares of common stock to cover tax obligations related to restricted stock unit vesting.
Summary
- Joshua Aiello, Principal Accounting Officer of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction on January 2, 2026.
- The transaction involved the disposition of 241 shares of Common Stock.
- These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting of restricted stock units.
- The deemed price for the disposition was $4.31 per share.
- No shares were sold in the open market as a result of this transaction.
- Following this transaction, Joshua Aiello beneficially owns 18,885 shares of Common Stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 5
Explanation: This is a neutral, routine insider transaction for tax withholding purposes, not indicative of positive or negative sentiment regarding the company's performance or outlook.
Positives
- The transaction is a routine tax withholding event, not a discretionary market sale by the officer.
- The officer continues to hold a significant number of shares (18,885) after the transaction, indicating continued alignment with shareholder interests.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Industry Context
This filing details a routine insider transaction related to equity compensation, which is a standard practice across various industries for executive remuneration and does not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-market transaction for tax purposes.
- Employees: Reflects standard equity compensation practices for executives.
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of transaction for tax withholding related to restricted stock unit vesting. |
Keywords
Orchestra BioMed Holdings, OBIO, Joshua Aiello, Form 4, Insider Transaction, Stock Vesting, Tax Withholding, Restricted Stock Units, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.